The Patent Finder

Detection of Target Nucleic Acid Sequence by Pto Cleavage and Extension-Dependent Signaling Oligonucleotide Hybridization Assay

Seegene, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/KR2012/005281, filed Jul 3, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,868,980Detection of Target Nucleic Acid Sequence by Pto Cleavage and Extension-Dependent Signaling Oligonucleotide Hybridization Assay
In force
 · High confidence
Seegene, Inc.In force
High confidence
US 10,731,203Detection of Target Nucleic Acid Sequence by Pto Cleavage and Extension-Dependent Signaling Oligonucleotide Hybridization Assay
In force
 · High confidence
Seegene, Inc.In force
High confidence
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited